Skip to main content
ioMicroglia P2RY12 null/WT
P2RY12 ko het het hero IBA1 ICC
Cell culture media for the culture of ioMicroglia up to 10 days post-thaw
ioMicroglia P2RY12 knockout het and hom phagocytosis
ioMicroglia P2RY12 knockout het and hom cytokine secretion
bit.bio_Microglia_P2RY12_chemotaxis_phenotype
P2RY12 ko het het hero IBA1 ICC-1
Microglia P2RY12 het ko BF morphology
Micrgolia P2RY12 HET KO flow plots v3
bit.bio-co-culture-neurons-and-microglia
Phenotypic analysis of a tri-culture for CNS modelling using ioGlutamatergic Neurons, ioAstrocytes, and ioMicroglia
ioMicroglia mRNA transfection
P2RY12 ko het het hero IBA1 ICC
Cell culture media for the culture of ioMicroglia up to 10 days post-thaw
ioMicroglia P2RY12 knockout het and hom phagocytosis
ioMicroglia P2RY12 knockout het and hom cytokine secretion
bit.bio_Microglia_P2RY12_chemotaxis_phenotype
P2RY12 ko het het hero IBA1 ICC-1
Microglia P2RY12 het ko BF morphology
Micrgolia P2RY12 HET KO flow plots v3
bit.bio-co-culture-neurons-and-microglia
Phenotypic analysis of a tri-culture for CNS modelling using ioGlutamatergic Neurons, ioAstrocytes, and ioMicroglia
ioMicroglia mRNA transfection

cat no | io6015

ioMicroglia P2RY12 null/WT

Human iPSC-derived microglia model

  • Cryopreserved human iPSC-derived cells powered by opti-ox, that are ready for functional experiments in 4 days

  • Built to investigate the impact of P2RY12 knockout for neuroinflammation research

  • Consistently perform key phagocytic and cytokine secretion functions, and are co-culture compatible

Place your order

Due to high demand, media kits are temporarily available for delivery within the UK only. We are working to restore availability in the EU and US as soon as possible and apologise for any inconvenience.
P2RY12 ko het het hero IBA1 ICC

Human iPSC-derived microglia for neuroinflammation research

Cell culture media for the culture of ioMicroglia up to 10 days post-thaw

ioMicroglia Media Kit

Cell culture media kit for the culture of ioMicroglia up to 10 days post-thaw

Learn more about the product >

ioMicroglia P2RY12 knockout het and hom phagocytosis

Phagocytosis of ioMicroglia P2RY12null/wt is demonstrated comparably to the WT control and ioMicroglia P2RY12null/null

Phagocytosis was analysed at day 10 post-revival after incubation with 1 µg/0.33 cm2 pHrodo RED labelled E. coli particles for 24 hours +/- cytochalasin D control. The graph displays the proportion of cells phagocytosing E.coli over 24 hours. ioMicroglia P2RY12null/wt cells display a similar  proportion of phagocytosis compared to the ioMicroglia P2RY12null/null and WT control. Images were acquired every 30 mins on the Incucyte® looking at red fluorescence and phase contrast. Three technical replicates were performed experiment. 

ioMicroglia P2RY12 knockout het and hom cytokine secretion

Key cytokine secretion function displayed by ioMicroglia P2RY12 null/wt 

Cytokine secretion was analysed at day 10 post-revival after stimulation with LPS 100 ng/ml and IFNɣ 20 ng/ml for 24 hours. This revealed that ioMicroglia P2RY12null/wt cells display a similar level of cytokine secretion compared to the ioMicroglia P2RY12null/null and WT control. Supernatants were harvested and analysed using MSD V-plex Proinflammatory Kit. Three technical replicates were performed per experiment.

bit.bio_Microglia_P2RY12_chemotaxis_phenotype

ioMicroglia P2RY12 null/WT display clear ablation of ATP mediated chemotaxis

ioMicroglia Male (io1021), ioMicroglia P2RY12 null/WT, and ioMicroglia P2RY12 null/null (io6012) were plated onto Incucyte® Clearview 96-well Plate for Chemotaxis with 8 μm sized pores and 25 μM ATP in the basal compartment.

Cell movement through the pores onto the underside of the membrane was quantified with the Incucyte® S3 Live-Cell Analysis System using the Incucyte® Chemotaxis Analysis software (in collaboration with Sartorius).

A) The ratio of membrane coverage of the underside of the membrane to the top is plotted. N=6, two independent experiments, mean and SEM are shown.

B) Representative brightfield imaging of the underside of the transwell membranes at 62 h, blue shows the applied cell masking on each image.

As expected, clear ablation of ATP-mediated chemotaxis is seen both the ioMicroglia P2RY12 null/null and ioMicroglia P2RY12 null/WT cells.

P2RY12 ko het het hero IBA1 ICC-1

ioMicroglia P2RY12 null/wt express IBA1 comparably to the genetically matched wild-type control

Immunofluorescent staining on day 10 post-revival demonstrates similar homogenous expression of the microglia marker IBA1 and ramified morphology in ioMicroglia P2RY12 null/wt cells compared to the genetically matched wild-type control, ioMicroglia Male. 100X magnification.

Microglia P2RY12 het ko BF morphology

ioMicroglia P2RY12 null/wt show expected ramified morphology by day 10

ioMicroglia P2RY12null/wt cells mature rapidly and key ramified morphology can be identified by day 4 and continues through to day 10, similarly to the WT control. Day 1 to 10 post-thawing; 100x magnification.

Micrgolia P2RY12 HET KO flow plots v3

P2RY12 null/wt heterozygous knockout confirmed by flow cytometry analysis

Flow cytometry analysis of ioMicroglia P2RY12 null/WT demonstrates heterozygous knockout of the P2RY12 gene translating to the protein level. Microglia purity demonstrated by >95% expression of CD45, CD11b and CD14 expression.

Female donor-derived ioMicroglia form co-cultures with  ioGlutamatergic Neurons 

ioGlutamatergic Neurons (io1001) were cultured to day 10 post-thaw. Female donor-derived ioMicroglia (io1029) cultured to either day 1 or day 10 post-thaw were added directly to day 10 ioGlutamatergic Neurons. The co-cultures were maintained for a further 6 days. Representative video showing that female donor-derived ioMicroglia form a stable co-culture with ioGlutamatergic Neurons. Live imaging was performed in 6.5-minute intervals over a time period of 3 hours and 31 minutes using the 3D Cell Explorer 96focus Nanolive Imaging system.

View the co-culture protocol used to generate this data.

Phenotypic analysis of a tri-culture for CNS modelling using ioGlutamatergic Neurons, ioAstrocytes, and ioMicroglia

Phenotypic characterisation of a human iPSC-derived tri-culture using ioGlutamatergic Neurons, ioAstrocytes, and ioMicroglia

Using our fully optimised protocol, ioGlutamatergic Neurons (MAP2, red), ioMicroglia (IBA1, yellow) and ioAstrocytes (vimentin, cyan) were co-cultured to create a highly defined CNS model. High-resolution ICC analysis confirms the successful co-localisation and morphological health of three distinct cell types within a unified environment. By day 7, the protocol yields a highly consistent, integrated network suitable for complex cell modelling. DAPI (blue) highlights the total cell density and integrity of the culture. This protocol is compatible with derivative products of the three cell types, ensuring straightforward implementation across experimental workflows.

Download the optimised tri-culture protocol

ioMicroglia mRNA transfection

ioMicroglia are efficiently transfected with mRNA encoding GFP

ioMicroglia Male are efficiently transfected and show sustained long-term expression of mRNA encoding GFP. Cells were imaged throughout the experiment to assess transfection efficiency and evaluate potential cytotoxic effects of the transfection protocol. Day 4 images were captured prior to transfections on the same day.

Download the step-by-step protocol for lipid-based delivery of synthetic mRNA into ioMicroglia.

Vial limit exceeded

A maximum number of 20 vials applies. If you would like to order more than 20 vials, please contact us at orders@bit.bio.

Human iPSC-derived

model for neuroinflammation research

ioMicroglia P2RY12 null/WT are opti-ox deterministically programmed microglia engineered as a heterozygous knockout of the P2RY12 gene. P2RY12 is a purinergic receptor that plays essential roles in microglia motility and migration, and is critical for initiating microglial responses to inflammation and damage.

These cells offer a functional, rapidly maturing model to study the role of P2RY12 in neuroinflammation research, alongside a genetically matched wild-type control.

Two clones are available on request, all genetically matched to the wild type control, ioMicroglia Male. The knockout model cells and the wild-type control offer a physiologically relevant model to investigate the effect of P2RY12 on microglia cellular and molecular mechanisms.

Benchtop benefits

comparison_0

Making True Comparisons

Pair with the homozygous knockout and the genetically matched wild-type ioMicroglia to directly investigate the effect of P2RY12.

quick_0

Quick

Rapidly maturing cells that are ready to use in 4 days post-revival, in mono- and co-cultures.

functional_0

Functional

Display key phagocytic and cytokine secretion functions.

Cells arrive ready to plate


Microglia_timeline_4_days

ioMicroglia P2RY12 null/WT are delivered in a cryopreserved format and are programmed to rapidly mature upon revival in the recommended media. The protocol for the generation of these cells is a three-phase process: an Induction phase that is carried out at bit.bio, Phase 1: Stabilisation for 24 hours, Phase 2: Maturation for a further 9 days, Phase 3: the Maintenance phase. Cells are ready to use from day 4 for functional experiments as determined by the genetically matched wild type control ioMicroglia Male (io1021).

Product specifications

Starting material

Human iPSC line

Seeding compatibility

6, 12, 24, 96 & 384 well plates

Shipping info

Dry ice

Donor

Caucasian adult male (skin fibroblast),
Genotype APOE 3/3

Vial size

Small: >1.5 x 10⁶ viable cells

Quality control

Sterility, protein expression (ICC), and functional phagocytosis

Differentiation method

opti-ox deterministic cell programming

Recommended seeding density

40,000 to 80,000 cells/cm²

User storage

LN2 or -150°C

Format

Cryopreserved cells

Product use

ioCells are for research use only

Genetic modification

Heterozygous knockout mutation in the P2RY12 gene

Applications

Drug discovery and development
Neuroinflammation modelling
Phagocytosis assays
cytokine response assays
Co-culture studies

Available clones

io6015S: ioMicroglia P2RY12 null/wt (clone 747P1D1)
io6014S: ioMicroglia P2RY12 null/wt (clone 747P1C1)

 

Scale your study with volume pricing

Enabling scientists to use human cells in their research, running additional experiments without rationing cells or limiting experimental scale

 

Order quantity Total vials received Pricing tier 
1 - 9 packs 2 - 18 vials Standard price
10 - 49 packs 20 - 98 vials Automatic 10% discount
> 50 packs > 100 vials > Contact us for a quote

 

Academic pricing: Academic users can purchase any ioCells in 3-vial packs ($/€/£ 999 per pack), available year-round with any cell type combination.
Technical data

Highly characterised and defined

ioMicroglia P2RY12 null/WT express IBA1 comparably to the genetically matched wild-type control
P2RY12 ko het het hero IBA1 ICC-1
Immunofluorescent staining on day 10 post-revival demonstrates similar homogenous expression of the microglia marker IBA1 and ramified morphology in ioMicroglia P2RY12 null/WT cells compared to the genetically matched wild-type control, ioMicroglia Male. 100X magnification.

ioMicroglia P2RY12 null/WT show expected ramified morphology by day 10

Microglia P2RY12 het ko BF morphology

ioMicroglia P2RY12 null/WT cells mature rapidly and key ramified morphology can be identified by day 4 and continues through to day 10, similarly to the WT control. Day 1 to 10 post-thawing; 100x magnification.

 
P2RY12 null/WT homozygous knockout confirmed by flow cytometry analysis
Microglia P2RY12 HET KO flow plots v3
Flow cytometry analysis of ioMicroglia P2RY12 null/WT demonstrates the heterozygous knockout of the P2RY12 gene is translated to the protein level. Microglia purity demonstrated by >95% expression of CD45, CD11b and CD14 expression.

Cytokine secretion

Key cytokine secretion function displayed by ioMicroglia P2RY12 null/WT 

ioMicroglia P2RY12 knockout het and hom cytokine secretion

Cytokine secretion was analysed at day 10 post-revival after stimulation with LPS 100 ng/ml and IFNɣ 20 ng/ml for 24 hours. This revealed that ioMicroglia P2RY12 null/WT cells display a similar level of cytokine secretion compared to the ioMicroglia P2RY12 null/null and WT control. Supernatants were harvested and analysed using MSD V-plex Proinflammatory Kit. Three technical replicates were performed per experiment. 

Phagocytosis of E. coli

Phagocytosis capability of ioMicroglia P2RY12 null/WT is comparable to the WT control and ioMicroglia P2RY12 null/null
ioMicroglia P2RY12 knockout het and hom phagocytosis
ioMicroglia P2RY12 knockout het and hom degree of phagocytosis
Phagocytosis was analysed at day 10 post-revival after incubation with 1 µg/0.33 cm2 pHrodo RED labelled E. coli particles for 24 hours +/- cytochalasin D control. The graph displays 1) the proportion of cells phagocytosing E.coli and 2) the fluorescence intensity per cell demonstrating the degree of phagocytosis over 24 hours. ioMicroglia P2RY12 null/wt cells display a similar  proportion of phagocytosis compared to the ioMicroglia P2RY12 null/null and WT control. Images were acquired every 30 mins on the Incucyte® looking at red fluorescence and phase contrast. Three technical replicates were performed per experiment. 

Chemotaxis

ioMicroglia P2RY12 null/WT display clear ablation of ATP mediated chemotaxis 

bit.bio_Microglia_P2RY12_chemotaxis_phenotype

ioMicroglia Male (io1021), ioMicroglia P2RY12 null/WT, and ioMicroglia P2RY12 null/null (io6012) were plated onto Incucyte® Clearview 96-well Plate for Chemotaxis with 8 μm sized pores and 25 μM ATP in the basal compartment.

Cell movement through the pores onto the underside of the membrane was quantified with the Incucyte® S3 Live-Cell Analysis System using the Incucyte® Chemotaxis Analysis software (in collaboration with Sartorius).

A) The ratio of membrane coverage of the underside of the membrane to the top is plotted. N=6, two independent experiments, mean and SEM are shown.

B) Representative brightfield imaging of the underside of the transwell membranes at 62 h, blue shows the applied cell masking on each image.

As expected, clear ablation of ATP-mediated chemotaxis is seen both the ioMicroglia P2RY12 null/null and ioMicroglia P2RY12 null/WT cells.

Technical data

Cytokine secretion measured by MSD assay

Key cytokine secretion function displayed by ioMicroglia P2RY12 null/WT 

ioMicroglia P2RY12 knockout het and hom cytokine secretion

Cytokine secretion was analysed at day 10 post-revival after stimulation with LPS 100 ng/ml and IFNɣ 20 ng/ml for 24 hours. This revealed that iioMicroglia P2RY12 null/WT cells display a similar level of cytokine secretion compared to the ioMicroglia P2RY12 null/null and WT control. Supernatants were harvested and analysed using MSD V-plex Proinflammatory Kit. Three technical replicates were performed per experiment. 

Chemotaxis

ioMicroglia P2RY12 null/WT display clear ablation of ATP mediated chemotaxis

bit.bio_Microglia_P2RY12_chemotaxis_phenotype

ioMicroglia Male (io1021), ioMicroglia P2RY12 null/WT, and ioMicroglia P2RY12 null/null (io6012) were plated onto Incucyte® Clearview 96-well Plate for Chemotaxis with 8 μm sized pores and 25 μM ATP in the basal compartment.

Cell movement through the pores onto the underside of the membrane was quantified with the Incucyte® S3 Live-Cell Analysis System using the Incucyte® Chemotaxis Analysis software (in collaboration with Sartorius).

A) The ratio of membrane coverage of the underside of the membrane to the top is plotted. N=6, two independent experiments, mean and SEM are shown.

B) Representative brightfield imaging of the underside of the transwell membranes at 62 h, blue shows the applied cell masking on each image.

As expected, clear ablation of ATP-mediated chemotaxis is seen both the ioMicroglia P2RY12 null/null and ioMicroglia P2RY12 null/WT cells.

Multi-cellular models

Female donor-derived ioMicroglia form co-cultures with  ioGlutamatergic Neurons 

ioGlutamatergic Neurons (io1001) were cultured to day 10 post-thaw. Female donor-derived ioMicroglia (io1029) cultured to either day 1 or day 10 post-thaw were added directly to day 10 ioGlutamatergic Neurons. The co-cultures were maintained for a further 6 days. Representative video showing that female donor-derived ioMicroglia form a stable co-culture with ioGlutamatergic Neurons. Live imaging was performed in 6.5-minute intervals over a time period of 3 hours and 31 minutes using the 3D Cell Explorer 96focus Nanolive Imaging system.

mRNA transfection

ioMicroglia are efficiently transfected with mRNA encoding GFP
ioMicroglia mRNA transfection

ioMicroglia Male are efficiently transfected and show sustained long-term expression of mRNA encoding GFP. Cells were imaged throughout the experiment to assess transfection efficiency and evaluate potential cytotoxic effects of the transfection protocol. Day 4 images were captured prior to transfections on the same day.

How to culture ioMicroglia

In this video, our scientist will take you through the step-by-step process of how to thaw, seed and culture ioMicroglia.

Frequently Asked Questions (FAQs)

 

  • Why is the P2RY12 gene knockout relevant for disease modelling?

P2RY12 is a purinergic receptor that plays essential roles in microglia motility and migration, and is critical for initiating microglial responses to inflammation and damage.

 

  • Is there a genetically-matched wild-type control that can be used alongside the P2RY12 disease model in human iPSC-derived ioMicroglia?

bit.bit offers the P2RY12 heterozygous and homozygous mutations as well as a genetically-matched wild-type control, which provide a physiologically relevant model to investigate the impact of P2RY12 knockout on neuroinflammation.

 

  • Do the P2RY12 null/WT ioMicroglia display disease-relevant phenotypic differences compared to the wild-type?

P2RY12 null/WT ioMicroglia display a clear ablation of ATP-mediated chemotaxis compared to the genetically-matched wild-type control.

Product resources

Alzheimer’s Disease Pathogenesis - Emerging Role of Microglia

In this GEN webinar, hear from our distinguished expert, Dr Matthias Pawlowski, and learn about the emerging role of microglia in the pathogenesis of Alzheimer’s disease and their potential as a therapeutic target to treat this disease effectively.

5C_ioMicrogliaConfocal image-1-1

Expand your research

Click on the icons to find out more

GFP-expressing cells enable easy visualisation, tracking and isolation in complex multi-cell cultures
Light up your co-cultures
Track GFP ioMicroglia in complex multi-cell cultures
Expand your research
Light up your co-cultures
Track GFP ioMicroglia in complex multi-cell cultures
GFP-expressing cells enable easy visualisation, tracking and isolation in complex multi-cell cultures

Human iPSC-derived microglia engineered to constitutively express GFP enable easy visualisation, tracking and isolation of cells in complex multi-cell cultures.

Discover the data

Study disease mechanisms in microglia-neuron interactions in an in vitro co-culture model.
Model neurodegenerative disease with physiologically relevant co-cultures
Study disease mechanisms in microglia-neuron interactions
Expand your research
Model neurodegenerative disease with physiologically relevant co-cultures
Study disease mechanisms in microglia-neuron interactions
Study disease mechanisms in microglia-neuron interactions in an in vitro co-culture model.

Access 20 neuronal disease models and 4 microglia disease models with a single co-culture protocol.


View the co-culture protocol

Explore ioGlutamatergic Neuron Disease Models
Explore ioMicroglia Disease Models

hIPSC-derived microglial cells in multiple donor backgrounds for neuroinflammation studies.
Model diversity with ioMicroglia Female
De-risk compound screening with microglia from diverse backgrounds
Expand your research
Model diversity with ioMicroglia Female
De-risk compound screening with microglia from diverse backgrounds
hIPSC-derived microglial cells in multiple donor backgrounds for neuroinflammation studies.

Women are greatly underrepresented in drug development and clinical trials.
Introducing female-derived cells into the early stage of research and drug discovery can help to better address this disparity.

Key applications for Female ioMicroglia in neurodegeneration drug discovery
- Neuroinflammatory in vitro modelling
- Target ID and validation
- Compound screening

Discover the data

CRISPR-ready human iPSC-derived cells, which constitutively express Cas9.
Simplify gene knockouts and CRISPR screens
Have you considered CRISPRko-Ready ioMicroglia?
Expand your research
Simplify gene knockouts and CRISPR screens
Have you considered CRISPRko-Ready ioMicroglia?
CRISPR-ready human iPSC-derived cells, which constitutively express Cas9.

Built from our ioMicroglia Male and engineered to constitutively express Cas9.
With optimised guide RNA delivery protocols and high knockout efficiency, start measuring readouts from gene knockouts and CRISPR screens within days.
Save months of work by skipping complex cell line engineering and cell differentiation workflows.

Discover the data

ioCells catalogue

Human iPSC-derived cells

powered by opti-ox

Consistent. Defined. Scalable.

bitbio-cell_catalogue_header-with-tracker-Desktop-2500x1664